These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7026511)

  • 1. [Value of erythrocyte adherence tests (SRCA tests) in the diagnosis and therapy of superficial bladder tumors].
    Jakse G; Hofstädter F
    Helv Chir Acta; 1981 Aug; 48(3-4):499-501. PubMed ID: 7026511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on multiple mucosal biopsy in patients with bladder cancer. 3. Evaluation of ABH antigenicity in specimens of multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1649-62. PubMed ID: 3825814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The study of ABH isoantigen and T (Thomsen-Friedenreich) antigen of superficial urothelial tumor].
    Sasaki K
    Hokkaido Igaku Zasshi; 1984 Nov; 59(6):679-89. PubMed ID: 6530208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of ABH antigens and CEA for the prognosis of urothelial tumors].
    Hofstädter F; Jakse G
    Wien Klin Wochenschr; 1982 Jul; 94(14):366-8. PubMed ID: 7147976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of random biopsies of healthy mucosa in superficial bladder tumor].
    Fernández Gómez JM; Rodríguez Martínez JJ; Escaf Barmadah S; Pérez García J; García J; Casasola Chamorro J
    Arch Esp Urol; 2000 Nov; 53(9):785-97. PubMed ID: 11196385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The study of cell surface antigens in bladder tumors: ABH-isoantigen and Thomsen-Friedenreich antigen].
    Kobayashi H
    Hinyokika Kiyo; 1987 Apr; 33(4):535-44. PubMed ID: 3618425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific red cell adherence test and unspecific immune response in patients with superficial bladder cancer.
    Jakse G; Hofstädter F; Märk R
    Urol Int; 1981; 36(3):171-7. PubMed ID: 7025414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The specific erythrocyte adherence method in the study of ABH antigens on normal and neoplastic bladder epithelium].
    Ongaro G; Issi M; Gallo T; Garbeglio A; Ranieri A; Dalla Palma P
    Quad Sclavo Diagn; 1983 Jun; 19(2):242-61. PubMed ID: 6676774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of the Thomsen-Friedenreich antigen in bladder tumors].
    Fukatsu H; Yamada H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Nishikawa E; Yamada Y
    Hinyokika Kiyo; 1988 Feb; 34(2):260-7. PubMed ID: 3376818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood group antigens in transitional cell tumours of the urinary bladder. An immunohistochemical study.
    Juhl BR
    Dan Med Bull; 1994 Feb; 41(1):1-11. PubMed ID: 8187557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and therapy of superficial tumors of the urinary bladder].
    Babjuk M; Dvorácek J
    Cas Lek Cesk; 2002 Nov; 141(23):723-8. PubMed ID: 12650028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
    Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypically heterogeneous deletion of the ABH antigen from the transformed bladder urothelium. A scanning electron microscope study.
    De Harven E; He S; Hanna W; Bootsma G; Connolly JG
    J Submicrosc Cytol; 1987 Oct; 19(4):639-49. PubMed ID: 3430650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HL-A antigenicity in bladder tumors].
    Jakse G; Hofstädter F
    Helv Chir Acta; 1978 Jul; 45(3):313-6. PubMed ID: 701068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bladder tumors: prognostic value of surface antigens and carcinoembryonic antigens. A retrospective study].
    Hammou JC; Fella C; Vacant J; Veillon B; Brisset JM
    Ann Urol (Paris); 1984 Sep; 18(5):319-23. PubMed ID: 6529244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The usefulness of the carbohydrate antigen CA-50 in the prognosis of transitional-cell bladder carcinomas].
    Moreno Sierra J; Blanco Jímenez E; Silmi Moyano A; Ortega Heredia MD; Páramo González P; Maestro de las Casas ML; Fernández Lucas C; Ramírez Fernández JC; Luengo Alpuente S; Gómez Vegas A
    Arch Esp Urol; 1993 Nov; 46(9):775-8. PubMed ID: 8304791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ALA fluorescent diagnosis of bladder cancer].
    Al'-Shukri SKh; Danil'chenko DI; Kënig F; Shnorr D
    Urologiia; 2000; (5):48-50. PubMed ID: 11392226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat shock proteins HSP27, HSP60, HSP70, and HSP90: expression in bladder carcinoma.
    Lebret T; Watson RW; Molinié V; O'Neill A; Gabriel C; Fitzpatrick JM; Botto H
    Cancer; 2003 Sep; 98(5):970-7. PubMed ID: 12942564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.